Teach me thallasemia pathology, el5
thalassemia pathophysiology pathology alpha beta globin chain imbalance hemolysis
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 2927
thalassemia pathophysiology diagram globin chain imbalance

Hugging Face pmc clinical VQA raw
Page 0
| Type | What's deficient | What accumulates |
|---|---|---|
| α-thalassemia | Alpha chains (gene deletion) | Excess beta chains → form HbH (β4 tetramers) |
| β-thalassemia | Beta chains (gene mutation) | Excess alpha chains (the trouble-maker) |

| Problem | Mechanism | Clinical Result |
|---|---|---|
| Excess unpaired α-chains | Precipitate, oxidize membrane | Cell death in marrow (ineffective erythropoiesis) |
| Fragile RBCs that survive | Hemolysis in spleen/blood | Anemia |
| Body makes more marrow | Massive erythroid expansion | Bone deformity, hepatosplenomegaly |
| Hepcidin suppressed | Gut absorbs more iron | Iron overload → organ damage |
Tell me about hepcidin
hepcidin mechanism action iron regulation synthesis
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 11768
| When hepcidin is HIGH | When hepcidin is LOW |
|---|---|
| Binds ferroportin → triggers its internalization and degradation | Ferroportin stays on cell surface |
| Iron stays trapped inside enterocytes, macrophages, liver | Iron is exported into plasma freely |
| Serum iron ↓, ferritin ↑ | Serum iron ↑ |
| Stimulus | Signal | Why it makes sense |
|---|---|---|
| High iron stores | BMP6, BMP2 (from liver sinusoidal cells) via BMP/SMAD pathway | Body has enough iron — close the gate |
| High transferrin saturation | TfR2 + HFE sensing Fe³⁺-Tf | Circulating iron is high |
| Inflammation/infection | IL-6 → JAK2/STAT3 pathway → HAMP gene transcription | Starve bacteria of iron (nutritional immunity) |
| Stimulus | Signal | Why it makes sense |
|---|---|---|
| Iron deficiency | Low BMP6 | Body needs more iron — open the gate |
| Hypoxia | HIF pathway | Need more RBCs → need more iron |
| Increased erythropoiesis | ERFE (erythroferrone, from erythroblasts) | Bone marrow is expanding → feed it iron |
| Anemia | Indirect, via ERFE | Same as above |

| Condition | Hepcidin Level | Result |
|---|---|---|
| Hereditary hemochromatosis (HFE mutation, HJV mutation, etc.) | Inappropriately LOW | Iron overload — gut keeps absorbing, stores keep filling |
| Anemia of chronic disease/inflammation | Inappropriately HIGH | Iron trapped in macrophages, unavailable for erythropoiesis → functional iron deficiency |
| β-thalassemia | Suppressed by ERFE | Iron overload despite already high stores |
| IRIDA (Iron-Refractory Iron Deficiency Anemia — TMPRSS6 loss-of-function) | Inappropriately HIGH | Can't suppress hepcidin even when iron-deficient → iron deficiency unresponsive to oral iron |
Iron absorption and utilisation
iron absorption duodenum enterocyte DMT1 ferroportin dietary iron
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 11766
iron absorption intestinal enterocyte diagram

Hugging Face pmc clinical VQA raw
Page 0
| Type | Source | Absorption rate | Notes |
|---|---|---|---|
| Haem iron (Fe²⁺ in haem) | Red meat, liver, blood | ~25–30% | Absorbed directly as intact haem via HCP1; highly bioavailable |
| Non-haem iron (Fe³⁺) | Plants, fortified foods, supplements | ~5–10% | Must be reduced first; affected by diet enhancers/inhibitors |

| Destination | Amount | Purpose |
|---|---|---|
| Bone marrow erythroblasts | ~20–25 mg/day | Haemoglobin synthesis (the dominant consumer) |
| Liver (hepatocytes) | Storage | Stored as ferritin and haemosiderin |
| Muscle | Small amount | Myoglobin synthesis |
| All cells | Tiny amount | Mitochondrial cytochromes, enzymes (catalase, ribonucleotide reductase) |
Daily iron need for erythropoiesis: ~20–25 mg/day
Daily dietary absorption: ~1–2 mg/day
→ The other ~23 mg comes from RECYCLING senescent RBCs
| Protein | Location | Function |
|---|---|---|
| Ferritin | Liver, spleen, bone marrow, serum | Soluble, safe iron storage; serum ferritin reflects stores |
| Haemosiderin | Liver, spleen (when overloaded) | Insoluble aggregate of degraded ferritin; marker of iron overload |
Diet (Fe³⁺)
↓ DCYTB reduces → Fe²⁺
↓ DMT1 into enterocyte
↓ Ferroportin + hephaestin out → Fe³⁺
↓ Binds transferrin in plasma
↓
├──→ Bone marrow → Haemoglobin synthesis (70% of body iron)
├──→ Liver → Ferritin/haemosiderin storage
└──→ Muscle → Myoglobin
↓
RBC lives 120 days → Macrophage phagocytosis
↓ Haem oxygenase
Fe²⁺ released → Ferroportin → Transferrin → Cycle repeats